-
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells
Lantermans, H. C., Ma, F., Kuil, A., de Rooij, M. F. M., Bergkamp, N. D., van der Meer, W., van Buul, J. D., Smit, M. J., Kersten, M. J., Spaargaren, M. & Pals, S. T., 13 May 2025, In: Blood. 9, 9, p. 2307-2320 14 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma
Lantermans, H. C., Ma, F., Kuil, A., van Kesteren, S., Yasinoglu, S., Yang, G., Buhrlage, S. J., Wang, J., Gray, N. S., Kersten, M. J., Treon, S. P., Pals, S. T. & Spaargaren, M., Jul 2024, In: Leukemia. 38, 7, p. 1570-1580 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma (Journal of Hematology & Oncology, (2021), 14, 1, (11), 10.1186/s13045-021-01031-3)
Ren, Z., Lantermans, H., Kuil, A., Kraan, W., Arenzana-Seisdedos, F., Kersten, M. J., Spaargaren, M. & Pals, S. T., 1 Dec 2021, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 14, 1, 29.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
